| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| bisindolylmaleimide-i | rac-alpha serine/threonine-protein kinase | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | g2/mitotic-specific cyclin b1 | NA | Patented-recorded target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | cyclin-dependent kinase 1 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | checkpoint kinase-1 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | glycogen synthase kinase-3 beta | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | lck tyrosine protein kinase | NA | Successful target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | extracellular signal-regulated kinase 2 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | stress-activated protein kinase 2b | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | map kinase p38 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | stress-activated protein kinase 2a | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | stress-activated protein kinase jnk1 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | pkc-delta messenger rna | NA | Literature-reported target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | pkc-epsilon messenger rna | NA | Literature-reported target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | protein kinase c gamma | NA | Successful target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | protein kinase c zeta | NA | Patented-recorded target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | rho-associated protein kinase 1 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| bisindolylmaleimide-i | serine/threonine-protein kinase sgk1 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| click here to return to the previous page | ||||||||